We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
How to use a cost effectiveness analysis to evaluate your digital health product.
The What Works Network uses evidence to improve the design and delivery of public services.
How to use a micro-randomised trial to evaluate your digital health product.
Data on the real-world efficacy of the COVID-19 vaccines.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Information for patients, healthcare professionals and developers of new medicines
Using an ecological momentary assessment to evaluate your digital health product.
Refreshed checklist of efficiency measures for more cost effective prescribing.
How to use a factorial randomised controlled trial to evaluate your digital health product.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
How to use an interrupted time series to evaluate your digital health product.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Helping public health practitioners conducting evaluations – developing a logic model to represent how your intervention works.
Guidance on choosing evaluation study types and methods.
Sets out COVID-19 testing for hospice patients and staff.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).